Disease Severity and Durability of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Response: A View Through the Lens of the Second Year of the Pandemic

Liise Anne Pirofski

doi:10.1093/cid/ciab374

Disease Severity and Durability of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Response: A View Through the Lens of the Second Year of the Pandemic

Liise Anne Pirofski

Medicine

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	E1345-E1347
Journal	Clinical Infectious Diseases
Volume	73
Issue number	6
DOIs	https://doi.org/10.1093/cid/ciab374
State	Published - Sep 15 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1093/cid/ciab374

Cite this

@article{eca855276ac640dba542a1fa5539da98,

title = "Disease Severity and Durability of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Response: A View Through the Lens of the Second Year of the Pandemic",

author = "Pirofski, \{Liise Anne\}",

year = "2021",

month = sep,

day = "15",

doi = "10.1093/cid/ciab374",

language = "English (US)",

volume = "73",

pages = "E1345--E1347",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Disease Severity and Durability of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Response

T2 - A View Through the Lens of the Second Year of the Pandemic

AU - Pirofski, Liise Anne

PY - 2021/9/15

Y1 - 2021/9/15

UR - https://www.scopus.com/pages/publications/85116958413

UR - https://www.scopus.com/pages/publications/85116958413#tab=citedBy

U2 - 10.1093/cid/ciab374

DO - 10.1093/cid/ciab374

M3 - Comment/debate

C2 - 33905478

AN - SCOPUS:85116958413

SN - 1058-4838

VL - 73

SP - E1345-E1347

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 6

ER -

Disease Severity and Durability of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Response: A View Through the Lens of the Second Year of the Pandemic

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this